Morgan Stanley Essa Pharma Inc. Transaction History
Morgan Stanley
- $1.27 Trillion
- Q2 2024
A detailed history of Morgan Stanley transactions in Essa Pharma Inc. stock. As of the latest transaction made, Morgan Stanley holds 4,177,848 shares of EPIX stock, worth $24.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,177,848
Previous 4,178,548
0.02%
Holding current value
$24.3 Million
Previous $35.5 Million
38.05%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding EPIX
# of Institutions
34Shares Held
35.2MCall Options Held
37.7KPut Options Held
3.8K-
Bvf Inc San Francisco, CA8.75MShares$50.8 Million1.41% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.89MShares$45.8 Million0.69% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT4.21MShares$24.5 Million2.24% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.97MShares$17.2 Million0.8% of portfolio
-
Rtw Investments, LP New York, NY2.3MShares$13.4 Million0.2% of portfolio
About ESSA Pharma Inc.
- Ticker EPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,073,100
- Market Cap $256M
- Description
- ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...